Delivery Order SPE2DB25D3022-SPE2DB25FWBVD
- Not listed
- The Defense Logistics Agency awarded a $3,858.40 delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens, with a completion date of September 18, 2025. This is a firm fixed-price, non-set-aside contract utilizing competitive procurement procedures. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a continuation of the company's extensive federal pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens valued at $1,929.20 under a firm fixed price contract. The award, issued on August 4, 2025, with an ultimate completion date of August 25, 2025, represents a non-competitive delivery order executed without set-aside provisions. AmerisourceBergen will perform this pharmaceutical supply delivery from its Corporate Office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Nemluvio 30 mg pens valued at $1,929.20. This firm fixed-price delivery order was competitively awarded without set-aside on October 14, 2025, with an ultimate completion date of November 4, 2025. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $1,929.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Nemluvio 30 mg pens. The contract, which represents a child order under a larger indefinite delivery vehicle, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 9, 2025. This delivery order was competitively awarded with no set-aside designation, reflecting...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,858.40 to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens, with a completion date of September 17, 2025. This firm fixed-price delivery order, issued on August 26, 2025, was competitively awarded without set-aside designation and represents a pediatric delivery against AmerisourceBergen's larger pharmaceutical supply agreement with the agency. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, the...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $7,716.80 delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens, with an ultimate completion date of August 20, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,929.20 to AmerisourceBergen Drug Corp for the supply of Nemluvio 30 mg pens, with an ultimate completion date of August 11, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA 19428. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $3,858.40 to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens under contract 4569273202. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 22, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and is fulfilling this order from its corporate office location. This...
- The Defense Logistics Agency awarded a $1,929.20 delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens, with an ultimate completion date of October 14, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and will be performed in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $3,858.40 delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens, with an ultimate completion date of July 16, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order represents a single transaction within the...
- SPE2DB25D3022Indefinite Delivery Contract
- SPE2DB25D3022-SPE2DB25FWBVDDelivery Order
The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens valued at $1,929.20. This firm fixed price order was competitively awarded without set-aside restrictions and must be completed by July 18, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. The parent IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The company's contract portfolio demonstrates its capacity to fulfill federal pharmaceutical requirements across multiple therapeutic domains through competitive delivery orders with both small and substantial order values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 6/26/25 |